Skin stem cells used to generate new brain cells – Science Daily
|
Skin stem cells used to generate new brain cells
Science Daily The finding marks an important step in the use of induced pluripotent stem (iPS) cells for targeted approaches to better understand and potentially treat neurological diseases such as Alzheimer’s. These iPS cells are derived from existing adult skin … |
|
Skin stem cells used to generate new brain cells
Science Daily The finding marks an important step in the use of induced pluripotent stem (iPS) cells for targeted approaches to better understand and potentially treat neurological diseases such as Alzheimer’s. These iPS cells are derived from existing adult skin … |
|
EMA designates uniQure’s gene therapy for hemophilia a priority
Labiotech.eu (blog) Following a Breakthrough Designation from the FDA earlier this year, the Dutch biotech has scored the European equivalent for AMT-060. Since its claim to fame, Glybera, fell from grace to become a commercial failure, uniQure has been on the rebound. |
|
MPEG LA Invites CRISPR-Cas9 Patents to be Pooled in a One-Stop License
Yahoo Finance World licensing leader MPEG LA, LLC today invited holders of CRISPR-Cas9 patents to participate in the creation of a global CRISPR-Cas9 Joint Licensing Platform that will make their groundbreaking technologies widely accessible. “Pooling the … |
P&T Community |
International Stem Cell Corporation Completes First Cohort In Parkinson’s Disease Clinical Trial
P&T Community CARLSBAD, Calif., April 25, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today announced that … StemGenex Recognizes Parkinson’s Awareness MonthYahoo Finance |
PR Newswire |
International Stem Cell Corporation Completes First Cohort In Parkinson’s Disease Clinical Trial
Nasdaq CARLSBAD, Calif., April 25, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today announced that … StemGenex Recognizes Parkinson’s Awareness MonthYahoo Finance |
PR Newswire |
International Stem Cell Corporation Completes First Cohort In Parkinson’s Disease Clinical Trial
GlobeNewswire (press release) CARLSBAD, Calif., April 25, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today announced that … StemGenex Recognizes Parkinson’s Awareness MonthYahoo Finance |